Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field (Q26786281)

Europe PubMed Central

23 March 2019

Europe PubMed Central

20 June 2019

Europe PubMed Central

Production of glycoprotein vaccines in Escherichia coli

2 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Diversity of the human intestinal microbial flora

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Population-based epidemiology and microbiology of community-onset bloodstream infections

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Escherichia coli ST131: The quintessential example of an international multiresistant high-risk clone

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Bacterial self-defence: how Escherichia coli evades serum killing.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Resistance profiles of urinary tract infections in general practice--an observational study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Glycoconjugate vaccines and immune interference: A review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Biosynthesis and assembly of capsular polysaccharides in Escherichia coli

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

The structures of Escherichia coli O-polysaccharide antigens.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Serum antibodies to outer membrane proteins of Escherichia coli in healthy persons and patients with bacteremia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Escherichia coli in extra-intestinal infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Escherichia coli and Klebsiella vaccines and immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Escherichia coli serotyping and disease in man and animals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Protective capacity of antibodies against Escherichia coli and K antigens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Extensive dissemination of extended spectrum β-lactamase-producing Enterobacteriaceae in a Dutch nursing home

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Clinical and microbiological determinants of infection after transrectal prostate biopsy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Safety and Immunogenicity of Escherichia coli 018 O-Specific Polysaccharide (O-PS)-Toxin A and O-PS-Cholera Toxin Conjugate Vaccines in Humans

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Prevalence of antibiotic resistance in US hospitals.

31 May 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

Burden of community-onset Escherichia coli bacteremia in seniors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

The Importance of the K1 Capsule in Invasive Infections Caused by Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV429

Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676548

Quality control of polyvalent pneumococcal polysaccharide-protein conjugate vaccine by nephelometry

28 November 2018

1 reference

12 December 2020

Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome

1 reference

12 December 2020

Rapid microarray-based DNA genoserotyping of Escherichia coli

1 reference

12 December 2020

TheEscherichia coliK1 Capsule Shares Antigenic Determinants with the Human Gangliosides GM3 and GD3

1 reference

12 December 2020

Safety And Immunogenicity Of A Polyvalent Escherichia Coli Vaccine In Human Volunteers

1 reference

12 December 2020

Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines

1 reference

12 December 2020

Identifiers

DOI

10.1093/INFDIS/JIV429

1 reference

release_uibb2gwmgrfn7nnrdyomcumfr4

Fatcat ID

0 references

1 reference

1 reference

PubMed publication ID

26333944

1 reference